Muscarinic M1, M3, Nicotinic,GABAA and GABAB Receptor ...

Fischer CP, Perstrup LB, Berntsen A, Eskildsen P, Pedersen BK. (2005). Elevated
plasma interleukin–18 is a marker of insulin–resistance in type 2 diabetic and
non–diabetic humans. Clin Immunol, 117: 152–160.
Fisher SK, Agranoff BW. (1987). Receptor activation and inositol lipid hydolysis in
neural tissues. Journal of Neurochemistry, 48: 999–1017.
Fladeby C, Skar R, Serck–Hanssen G. (2003). Distinct regulation of glucose transport
and GLUT1/GLUT3 transporters by g lucose deprivation and IGF–I in chromaffin
cells. Biochim Biophys Acta, 1593: 201–208.
Flanagan DE, Evans ML, Monsod TP, Rife F. (2003). The influence of insulin on
circulating ghrelin. Am J Physiol Endocrinol Metab, 284: 313–316.
Flechtner I, de Lonlay P, Polak M. (2006). Diabetes and hypoglycaemia in young
children and mutations in the Kir6.2 subunit of the potassium channel Therapeutic
consequences. Diabetes Metab, 32: 569–580.
Frazier CJ, Buhler AV, Weiner JL, Dunwiddie TV. (1998). Synaptic potentials
mediated via alpha–bungarotoxin–sensitive nicotinic acetylcholine receptors in rat
hippocampal interneurons, J Neurosci, 8228–8235.
French JA, Williamson PD, Thadani VM, Darcey TM, Mattson RH, Spencer SS,
Spencer DD. (1993). Characteristics of medial temporal lobe epilepsy: I. Results
of history and physical examination. Ann Neurol, 34: 774–780.
Frier BM. (2008). How hypoglycaemia can affect the life of a person with diabetes.
Diabetes Metab Res Rev, 24: 87–92.